Connect your AI

EXOZ EXOZ Finance Lease Liability - Undiscounted Excess Amount

Finance Lease Liability - Undiscounted Excess Amount at other companies

West Pharmaceutical ServicesWST

——

Other financials

Income statement

Revenue$17.5K—

Operating income-$2.4M-22.4%

Net income-$2.4M-27.7%

EPS (diluted)-$0.28-27.3%

Balance sheet

Cash & equivalents$1.4M-83.0%

Total debt$1.2M-8.8%

Total equity$1.5M-82.8%

Total assets$4.0M-65.1%

Cash flow

Operating cash flow-$1.5M-34.5%

CapEx$57.6K+85.5%

Free cash flow-$1.6M-35.8%

Valuation

Market cap$76.8M-5.6%

Enterprise value$76.57M+1.0%

P/S1,096.1×—

Profitability

Operating margin-14,489.6%—

Net margin-2,909.1%—

FCF margin-10,117.8%—

Returns & leverage

Return on equity-185.8%—

Debt / equity0.8×+0.6×

Current ratio1.3×-5.2×

Where this comes from

Reported directly by EXOZ in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount.

The official record: EXOZ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about EXOZ's finance lease liability - undiscounted excess amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is EXOZ's finance lease liability - undiscounted excess amount?: EXOZ (EXOZ) reported finance lease liability - undiscounted excess amount of $8.2K in Q1 2026.
What does finance lease liability - undiscounted excess amount mean?: This represents the total undiscounted future cash payments required for finance leases, excluding the recognized lease liability. It provides visibility into the long-term contractual obligations for leased assets that are not yet reflected as current debt. Monitoring this helps investors understand the full scale of off-balance sheet or future lease commitments.